Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype

References

• Ochs HD, Hitzig WH. History of primary immunodeficiency diseases. Curr Opin Allergy Clin Immunol. 2012;12:577–587.
   PubMed Web of Science ®Google Scholar
• Al-Herz W, Bousfiha A, Casanova JL, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2014;5:162.
   PubMed Web of Science ®Google Scholar
• Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118:2653–2655.
   PubMed Web of Science ®Google Scholar
• Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood. 2011;118:2656–2658.
   PubMed Web of Science ®Google Scholar
• Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43:929–931.
   PubMed Web of Science ®Google Scholar
• Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123:809–821.
   PubMed Web of Science ®Google Scholar
• Hirabayashi S, Wlodarski MW, Kozyra E, et al. Heterogeneity of GATA2-related myeloid neoplasms. Int J Hematol. 2017;106:175–182.
   PubMed Web of Science ®Google Scholar
• Hahn CN, Chong CE, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43:1012–1017.
   PubMed Web of Science ®Google Scholar
• Pasquet M, Bellanne-Chantelot C, Tavitian S, et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood. 2013;121:822–829.
   PubMed Web of Science ®Google Scholar
• Wlodarski MW, Collin M, Horwitz MS. GATA2 deficiency and related myeloid neoplasms. Semin Hematol. 2017;54:81–86.
   PubMed Web of Science ®Google Scholar
• Kazenwadel J, Secker GA, Liu YJ, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood. 2012;119:1283–1291.
   PubMed Web of Science ®Google Scholar
• Orkin SH. Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet. 2000;1:57–64.
   PubMed Web of Science ®Google Scholar
• Bresnick EH, Lee HY, Fujiwara T, et al. GATA switches as developmental drivers. J Biol Chem. 2010;285:31087–31093.
   PubMed Web of Science ®Google Scholar
• Rodrigues NP, Tipping AJ, Wang Z, et al. GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia. Int J Biochem Cell Biol. 2012;44:457–460.
   PubMed Web of Science ®Google Scholar
• Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371:221–226.
   PubMed Web of Science ®Google Scholar
• Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood. 1992;80:575–581.
   PubMed Web of Science ®Google Scholar
• Vicente C, Conchillo A, Garcia-Sanchez MA, et al. The role of the GATA2 transcription factor in normal and malignant hematopoiesis. Crit Rev Oncol Hematol. 2012;82:1–17.
   PubMed Web of Science ®Google Scholar
• Tsai FY, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 1997;89:3636–3643.
   PubMed Web of Science ®Google Scholar
• Ezoe S, Matsumura I, Nakata S, et al. GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. Blood. 2002;100:3512–3520.
   PubMed Web of Science ®Google Scholar
• de Pater E, Kaimakis P, Vink CS, et al. Gata2 is required for HSC generation and survival. J Exp Med. 2013;210:2843–2850.
   PubMed Web of Science ®Google Scholar
• Heyworth C, Gale K, Dexter M, et al. A GATA-2/estrogen receptor chimera functions as a ligand-dependent negative regulator of self-renewal. Genes Dev. 1999;13:1847–1860.
   PubMed Web of Science ®Google Scholar
• Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555–562.
   PubMed Web of Science ®Google Scholar
• Tipping AJ, Pina C, Castor A, et al. High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. Blood. 2009;113:2661–2672.
   PubMed Web of Science ®Google Scholar
• Guiu J, Shimizu R, D'Altri T, et al. Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling. J Exp Med. 2013;210:71–84.
   PubMed Web of Science ®Google Scholar
• de Pooter RF, Schmitt TM, de la Pompa JL, et al. Notch signaling requires GATA-2 to inhibit myelopoiesis from embryonic stem cells and primary hemopoietic progenitors. J Immunol. 2006;176:5267–5275.
   PubMed Web of Science ®Google Scholar
• Papaemmanuil E, Gerstung M, Malcovati L, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122:3616–3627. quiz 3699.
   PubMed Web of Science ®Google Scholar
• Yan XJ, Xu J, Gu ZH, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43:309–315.
   PubMed Web of Science ®Google Scholar
• Luesink M, Hollink IH, van der Velden VH, et al. High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia. Blood. 2012;120:2064–2075.
   PubMed Web of Science ®Google Scholar
• Fasan A, Eder C, Haferlach C, et al. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Leukemia. 2013;27:482–485.
   PubMed Web of Science ®Google Scholar
• Shiba N, Funato M, Ohki K, et al. Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia. Br J Haematol. 2014;164:142–145.
   PubMed Web of Science ®Google Scholar
• Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–447.
   PubMed Web of Science ®Google Scholar
• Greif PA, Dufour A, Konstandin NP, et al. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood. 2012;120:395–403.
   PubMed Web of Science ®Google Scholar
• Wlodarski MW, Hirabayashi S, Pastor V, et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2016;127:1387–1397. quiz 1518.
   PubMed Web of Science ®Google Scholar
• West RR, Hsu AP, Holland SM, et al. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica. 2014;99:276–281.
   PubMed Web of Science ®Google Scholar
• DiNardo CD, Bannon SA, Routbort M, et al. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC). Clin Lymphoma Myeloma Leuk. 2016;16:417–428. e412.
   PubMed Web of Science ®Google Scholar
• Sekhar M, Pocock R, Lowe D, et al. Can somatic GATA2 mutation mimic germ line GATA2 mutation? Blood Adv. 2018;2:904–908.
   PubMed Web of Science ®Google Scholar
• Mace EM, Hsu AP, Monaco-Shawver L, et al. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood. 2013;121:2669–2677.
   PubMed Web of Science ®Google Scholar
• Maciejewski-Duval A, Meuris F, Bignon A, et al. Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations. J Leukoc Biol. 2016;99:1065–1076.
   PubMed Web of Science ®Google Scholar
• Schlums H, Jung M, Han H, et al. Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells. Blood. 2017;129:1927–1939.
   PubMed Web of Science ®Google Scholar
• Vinh DC, Patel SY, Uzel G, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115:1519–1529.
   PubMed Web of Science ®Google Scholar
• Camargo JF, Lobo SA, Hsu AP, et al. MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis. 2013;57:697–699.
   PubMed Web of Science ®Google Scholar
• Dickinson RE, Milne P, Jardine L, et al. The evolution of cellular deficiency in GATA2 mutation. Blood. 2014;123:863–874.
   PubMed Web of Science ®Google Scholar
• Collin M, Dickinson R, Bigley V. Haematopoietic and immune defects associated with GATA2 mutation. Br J Haematol. 2015;169:173–187.
   PubMed Web of Science ®Google Scholar
• Goardon N, Marchi E, Atzberger A, et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell. 2011;19:138–152.
   PubMed Web of Science ®Google Scholar
• Doulatov S, Notta F, Laurenti E, et al. Hematopoiesis: a human perspective. Cell Stem Cell. 2012;10:120–136.
   PubMed Web of Science ®Google Scholar
• Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol. 2010;135:223–235.
   PubMed Web of Science ®Google Scholar
• Lim KC, Hosoya T, Brandt W, et al. Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J Clin Invest. 2012;122:3705–3717.
   PubMed Web of Science ®Google Scholar